Inventor
KUO GEE-HONG
US59 patents
⚠️ This page may combine multiple inventors who share the name “KUO GEE-HONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
26 patentsUS7301050B2Nov 27, 2007
4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
JANSSEN PHARMACEUTICA NV64 citations97
US7635718B2Dec 22, 2009
4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
JANSSEN PHARMACEUTICA NV48 citations96
US7425649B2Sep 16, 2008
4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
JANSSEN PHARMACEUTICA NV20 citations92
US7125878B2Oct 24, 2006
Substituted pyrroline kinase inhibitors
JANSSEN PHARMACEUTICA NV33 citations92
US7598292B2Oct 6, 2009
4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
JANSSEN PHARMACEUTICA NV10 citations84
US7598416B2Oct 6, 2009
4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
JANSSEN PHARMACEUTICA NV12 citations84
US7750048B2Jul 6, 2010
GPR40 agonists
JANSSEN PHARMACEUTICA NV15 citations82
US7678786B2Mar 16, 2010
Benzoazepin-oxy-acetic acid derivatives as PPAR-delta agonists used for the increase of HDL-C, lower LDL-C and lower cholesterol
JANSSEN PHARMACEUTICA NV8 citations82
US7928238B2Apr 19, 2011
1,2,3,4-tetrahydro-quinoline derivatives as CETP inhibitors
JANSSEN PHARMACEUTICA NV7 citations81
US7524858B2Apr 28, 2009
Substituted pyrroline kinase inhibitors
JANSSEN PHARMACEUTICA NV6 citations73
US11014917B2May 25, 2021
5-fluoro-c-(aryl or heterocyclyl)-glycoside derivatives useful as dual SGLT1 / SGLT2 modulators
JANSSEN PHARMACEUTICA NV0 citations62
US7786135B2Aug 31, 2010
Substituted pyrroline kinase inhibitors
JANSSEN PHARMACEUTICA NV2 citations62
US7781450B2Aug 24, 2010
Substituted pyrroline kinase inhibitors
JANSSEN PHARMACEUTICA NV2 citations62
US7705015B2Apr 27, 2010
Substituted pyrroline kinase inhibitors
JANSSEN PHARMACEUTICA NV2 citations62
US7205298B2Apr 17, 2007
Substituted triazine kinase inhibitors
JANSSEN PHARMACEUTICA NV6 citations62
US7015329B2Mar 21, 2006
4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
JANSSEN PHARMACEUTICA NV4 citations62
US10662170B2May 26, 2020
Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes
JANSSEN PHARMACEUTICA NV0 citations52
US10131648B2Nov 20, 2018
Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes
JANSSEN PHARMACEUTICA NV0 citations52
US9790198B2Oct 17, 2017
Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes
JANSSEN PHARMACEUTICA NV0 citations52
US9724322B2Aug 8, 2017
4-(phenoxyalkyl)thio)-phenoxyacetic acids and analogs
JANSSEN PHARMACEUTICA NV0 citations52
US8008513B2Aug 30, 2011
4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
JANSSEN PHARMACEUTICA NV0 citations52
US7875744B2Jan 25, 2011
4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
JANSSEN PHARMACEUTICA NV0 citations52
US7498351B2Mar 3, 2009
4-((Phenoxyalkyl)thio)-phenoxyacetic acids and analogs
JANSSEN PHARMACEUTICA NV1 citations52
US10696662B2Jun 30, 2020
5-fluoro-C-(aryl or heterocyclyl)-glycoside derivatives useful as dual SGLT1 / SGLT2 modulators
JANSSEN PHARMACEUTICA NV0 citations51
US9012412B2Apr 21, 2015
Dual SGLT1/SGLT2 inhibitors
JANSSEN PHARMACEUTICA NV0 citations51
US9771375B2Sep 26, 2017
Indazole compounds useful as ketohexokinase inhibitors
JANSSEN PHARMACEUTICA NV0 citations50
KUO GEE-HONG
5 patentsUS8106095B2Jan 31, 2012
4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
KUO GEE-HONG43 citations96
US8518997B2Aug 27, 2013
4-(phenoxyalkyl)thio)-phenoxyacetic acids and analogs
KUO GEE-HONG2 citations61
US8450371B2May 28, 2013
4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
KUO GEE-HONG0 citations51
US8258177B2Sep 4, 2012
4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
KUO GEE-HONG0 citations51
US8633184B2Jan 21, 2014
Benzoazepin-oxy-acetic acid derivatives as PPAR-delta agonists used for the increase of HDL-C, lower LDL-C and lower cholesterol
KUO GEE-HONG0 citations50
STERLING WINTHROP INC
5 patentsUS5330992AJul 19, 1994
1-cyclopropyl-4-pyridyl-quinolinones
STERLING WINTHROP INC294 citations96
US5523312AJun 4, 1996
Antipicornaviral agents
STERLING WINTHROP INC21 citations92
US5514692AMay 7, 1996
Substituted quinoline derivatives useful as antipiconaviral agents
STERLING WINTHROP INC20 citations92
US5552420ASep 3, 1996
Therapeutic phenoxyalkylazoles and phenoxyalkylazines
STERLING WINTHROP INC18 citations82
US5356903AOct 18, 1994
1-cyclopropyl-4-pyridyl-quinolines
STERLING WINTHROP INC13 citations73
ORTHO MCNEIL PHARM INC
5 patentsUS6710048B2Mar 23, 2004
Pyrazine derivatives as modulators of tyrosine kinases
ORTHO MCNEIL PHARM INC25 citations91
US6384035B1May 7, 2002
Heterocycles useful in the treatment of benign prostatic hyperplasia
ORTHO MCNEIL PHARM INC18 citations91
US6828327B2Dec 7, 2004
Macroheterocylic compounds useful as kinase inhibitors
ORTHO MCNEIL PHARM INC18 citations82
US6362338B1Mar 26, 2002
Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia
ORTHO MCNEIL PHARM INC1 citations52
US6063785AMay 16, 2000
Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia
ORTHO MCNEIL PHARM INC1 citations52
SANOFI SA
4 patentsUS5618821AApr 8, 1997
Therapeutic phenoxyalkylheterocycles
SANOFI SA13 citations74
US5846986ADec 8, 1998
Therapeutic phenoxyalkylazoles and phenoxyalkylazines
SANOFI SA12 citations73
US5763461AJun 9, 1998
Therapeutic phenoxyalkylheterocycles
SANOFI SA13 citations73
US5750550AMay 12, 1998
2-(pyrazol-5-yl-oxymethyl)-1,2-benzisothiazol-3 (2H)-One 1, 1-dioxides and compositions and method of use thereof
SANOFI SA11 citations73
STERLING DRUG INC
2 patentsSANOFI WINTHROP INC
1 patentORTH MCNEIL PHARMACEUTICAL INC
1 patentZHANG XUQING
1 patentShowing the top 50 of 59 patents by PatentIndex Score.